Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Zepp Health (ZEPP) over the last 10 years, with Q3 2025 value amounting to $1.0 billion.

  • Zepp Health's Short-term Investments fell 7911.73% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year decrease of 7911.73%. This contributed to the annual value of $997.0 million for FY2024, which is 1456176.47% up from last year.
  • According to the latest figures from Q3 2025, Zepp Health's Short-term Investments is $1.0 billion, which was down 7911.73% from $1.0 billion recorded in Q2 2025.
  • Zepp Health's Short-term Investments' 5-year high stood at $6.0 billion during Q1 2024, with a 5-year trough of $2.9 million in Q1 2021.
  • Its 5-year average for Short-term Investments is $2.9 billion, with a median of $3.0 billion in 2021.
  • In the last 5 years, Zepp Health's Short-term Investments plummeted by 8365.34% in 2021 and then surged by 19888601.4% in 2022.
  • Quarter analysis of 5 years shows Zepp Health's Short-term Investments stood at $6.4 million in 2021, then surged by 89.93% to $12.2 million in 2022, then crashed by 45.0% to $6.7 million in 2023, then skyrocketed by 14767.81% to $997.0 million in 2024, then grew by 2.51% to $1.0 billion in 2025.
  • Its Short-term Investments stands at $1.0 billion for Q3 2025, versus $1.0 billion for Q2 2025 and $1.0 billion for Q1 2025.